|Life Science Washington is proud to be hosting the 19th Annual Life Science Innovation Northwest (LSINW) conference on April 24 – 25, 2019 at the Washington State Convention Center in Seattle.
Life Science Innovation Northwest is the Pacific Northwest’s biggest annual life science conference. A two-day event bringing together investors, public and private life science organizations, research institutions, scientists, entrepreneurs, and the global health community to discuss and feature some of the most compelling technology breakthroughs of our time.
This year’s program is shaping up to be the best one yet! We are fortunate to have life science industry superstar presenters, including Dr. Roger Perlmutter, EVP & President of Merck Research Laboratories, Professor David Baker, Director of the Institute of Protein Design at University of Washington, Simone Fishburn, Vice President and Executive Editor of BioCentury, and an expansive list of angel investors: AoA, Keiretsu, SWAN, and WINGS, top venture capitalist firms including 5AM Ventures, AbbVie Ventures, Frazier Healthcare Partners, NEA, OrbiMed Healthcare Fund Management, M.H. Carnegie & Co., SpringRock Ventures, Versant Ventures, WRF Capital, medical device and digital health experts, and scientific and industry leaders from cellular and immunotherapy and gene editing research institutes and companies. We are very excited to hear the latest federal health policy developments from a panel comprised of senior staff from Capitol Hill, the FDA, and NIH. Additionally, we look forward to celebrating our latest Hall of Fame award recipients.
2019 CONFERENCE HIGHLIGHTS
* For complete conference details, we encourage you to thoroughly explore the conference website.
On April 24th, we are very lucky to have as our keynote speaker Roger M. Perlmutter, MD, PhD.
Dr. Perlmutter is executive vice president and president of Merck Research Laboratories. Prior to his current role, he was EVP and head of R&D at Amgen from 2001 to 2012 and held leadership positions of increasing responsibility at Merck from 1997 to 2001.
Previously, Dr. Perlmutter was professor and chairman of Immunology, University of Washington, and a Howard Hughes Medical Institute investigator. He received his M.D. and Ph.D. degrees from Washington University, and pursued clinical training in internal medicine at the Massachusetts General Hospital and the University of California, San Francisco.
On April 25th, we are kicking-off the day’s events with a “fireside chat” between prolific inventor and entrepreneur Professor David Baker and Simone Fishburn, Executive Editor of BioCentury. They will discuss the latest developments in next-generation protein-based therapeutics.
Our six featured expert panels are packed with industry leaders from a host of life science sectors, joining together to discuss the latest developments in cellular immunotherapy, trends in medical device investing, how to build a successful digital health venture, and so much more.
• Next Frontiers in Cellular Immunotherapy
• Politics and Policy in Innovation and Health Care
• Opportunities and Challenges in Gene Editing
• Issues and Trends in Venture Investing
• Current Trends in Medical Device Investing
• Lessons Learned in Angel Investing
• The C-SATS Story: Building a Successful Digital Health Venture
JOB & INTERNSHIP FAIR
Finally, don’t miss the newest addition to the conference, the Job & Internship Fair. One of Life Science Washington’s strategic initiatives is to build a thriving workforce and recruit new talent into the industry. As a way to support this, we are hosting a job fair on April 25th from 9 AM – 1 PM. This opportunity is free for job seekers and students. You can learn more here.